Zeepay, the leading cross border payments company operating as a challenger mobile money company today announces a raise of US$10 million.
The medium-term debt raise, which forms part of its A.5 series, comes to support Zeepay in a bid to augment its fast growing remittance to wallet business. The raise was led by Symbiotics BV with US$9 million and supported by a Mauritius-based fund with US$1 million totalling US$10 million.
According to the Founder and Managing Director, Andrew Takyi-Appiah I, the raise was necessary and comes at the time when we are planning to increase our annual turnover from US$1.5 billion circa 2021 to US$200 billion over the next five years.
Godfried Boakye, CFO, mentioned that the raise had become mission critical as we expand our service offering and African expansion and well within a manageable Loan to value ratio of 9percent. This will help augment support from local African banks the likes of Ecobank, Fidelity Bank and Absa.
Kwabena Appenteng, Transaction Advisor at Verdant Capital, said: “we are delighted to see the close of this component of the round, and urge local financial institutions and pension funds to find their niche, to enable them to participate alongside international lenders in the future as we work to deepen the African fintech ecosystem.”
JLD & MB Legal Consultancy acted as legal counsel to Zeepay in connection with the funding. Zoe P. Takyi — Appiah, a senior partner of the firm mentioned, “this is another notable milestone for Zeepay. Indeed, the company continues to break boundaries and expand its borders. We are delighted that this transaction has been realized and to have been a part of it.”
